RxDoctor Payments DataLook up a doctor →

Wayne Batchelor, MD

Interventional Cardiology · Falls Church, VANPI 1639172885

Payments from drug & device makers

$723,127in general payments, 2019–2025

Across 503 payments — averaging $1437.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$481K
  • Boston Scientific$107K
  • Medtronic$57K
  • Edwards Lifesciences$35K
  • Chiesi USA, Inc.$17K
  • Recor Medical Inc$10K
  • plus $16K from 17 others
$6,325in research payments, 2019–2025

Across 10 payments — averaging $632.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$4K
  • Recor Medical Inc$2K

What the payments were for

  • Consulting fees$85,90044%
  • Speaking & faculty fees$53,34527%
  • Travel & lodging$40,85421%
  • Food & beverage$15,8108%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$723,127 in reported general payments places this provider in the 95th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia

Medicare billing

Part B allowed, 2024
$98,834
Medicare patients
155
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$12,881
Metoprolol Succinate33$582
Rosuvastatin Calcium18$287
Isosorbide Mononitrate ErIsosorbide Mononitrate17$213
Atorvastatin Calcium21$208
Amlodipine Besylate25$152

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →